Market access in the German speaking markets

Pharma Market Access Insights - from Mtech Access

English - August 29, 2023 16:00 - 57 minutes - 39.9 MB
Life Sciences Science Business pharmaceutical pharma market access health economics heor medtech nhs healthcare Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The role of nursing in driving digital change in the NHS

Next Episode: 6 areas of UK health policy for Medtech to pay attention to

Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.

Clare and Stefan discuss:
- Preparing for access to Switzerland – a European market outside the EU
- Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
- Launching in Germany – is this still one of the most attractive European markets?
- The Financial Stabilisation Act in Germany – what this means for drug pricing

Learn more at: https://mtechaccess.co.uk/market-acce...

This episode was first broadcast as a live webinar in July 2023.

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.